Director, Patient Advocacy & Society Engagement, Europe

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

Opportunity

The Director, Patient Advocacy & Society Engagement will play an important role in driving RevMed’s strategy and execution of our EU patient advocacy, professional society engagement, and expanded access program/compassionate use work. As a part of the global medical affairs organization, this role will report into the Global Head of Advocacy and Society Engagement and play an integral role in helpin...